Cellular diversity through space and time: adding new dimensions to GBM therapeutic development.

Area of Science:

• Neuro-oncology
• Cancer Biology
• Genomics

Background:

• Glioblastoma (GBM) is the most aggressive adult primary brain cancer with a median survival of ~16 months.
• Limited therapeutic options and significant patient outcomes highlight an urgent need for novel treatment strategies.
• Recent advances reveal extensive GBM heterogeneity, driven by the tumor microenvironment (TME).

Purpose of the Study:

• To review advancements in understanding GBM spatiotemporal diversity.
• To emphasize the roles of hypoxia and immune cell interactions in driving tumor cell heterogeneity.
• To highlight high-resolution spatial methodologies for pre-clinical GBM research and clinical applications.

Main Methods:

• Review of current literature on glioblastoma heterogeneity.
• Analysis of the impact of tumor microenvironment factors (hypoxia, immune cells) on GBM.
• Discussion of high-resolution spatial and single-cell analysis techniques.

Main Results:

• The tumor microenvironment significantly influences GBM cellular plasticity and heterogeneity.
• Hypoxia and immune cell interactions are critical drivers of GBM malignancy.
• High-resolution spatial and single-cell analyses offer unprecedented insights into GBM biology.

Conclusions:

• Targeting hypoxia and immune-related mechanisms presents therapeutic opportunities for GBM.
• Single-cell and spatial exploration of GBM patient specimens can identify novel therapeutic targets.
• Advanced molecular tools are crucial for dissecting GBM complexity and improving patient outcomes.